Medibank Private Limited reported a substantial 27.5% increase in profit after tax to $638.7 million for the financial year ended 30 June 2026, demonstrating solid earnings growth driven by expanding revenues across the health insurance business. The result reflects the company’s ability to grow its core health insurance revenue by $640.5 million, or 8.0%, to $8,652.2 million, while also benefiting from a more significant 38.3% jump in other operating revenue to $463.0 million. Total revenue excluding net investment income reached $9,115.2 million, up 9.2% year-on-year, providing the foundation for the reported profit expansion.
The profit growth outpacing revenue growth suggests improving operational efficiency or favorable cost management during the period, though investors should note that the company’s net tangible assets per share declined from 62.7 cents to 56.7 cents. This apparent contradiction warrants attention, as it suggests capital has been deployed or allocated in ways that have reduced the tangible asset base per share even as profits have expanded. Understanding the drivers of this decline, whether through increased dividend payouts, capital returns, or other balance sheet movements, would be essential for a complete picture of shareholder value creation.
The dividend policy signals confidence in the earnings run. Medibank paid an interim dividend of 8.30 cents per share in March 2026 and determined a fully franked final dividend of 10.90 cents per share, payable in October. This brings total dividends to 19.2 cents for the full year, indicating the company is returning capital to shareholders through a combination of interim and final distributions. The full franking of both dividends is notable for Australian investors, as it allows eligible shareholders to offset franking credits against tax liabilities.
The health insurance revenue growth of 8.0% is particularly relevant given the competitive and regulated nature of the Australian health insurance sector. The expansion in other operating revenue at 38.3% suggests ancillary business lines or complementary services are gaining traction, though the base for other revenues remains smaller at $463 million compared to the core health insurance operations. The balance between these two revenue streams will be important to monitor as Medibank continues to evolve its business model beyond traditional health insurance.
For investors, the key takeaway is that Medibank has delivered solid earnings growth in FY26 underpinned by revenue expansion and operational improvements. The divergence between profit growth and declining tangible assets per share suggests scrutiny of capital allocation decisions is warranted. The next critical milestones will include the final dividend payment in October and any guidance provided on FY27 earnings trajectory. This announcement has been designated as price sensitive and flagged as material by the ASX.
View the full ASX announcement (PDF)
About Medibank Private Limited (ASX: MPL)
Medibank Private Limited is Australia’s largest private health insurer, providing health insurance coverage including hospital and ancillary services through the Medibank and ahm brands. The company operates through two main divisions: Health Insurance offering various coverage types, and Medibank Health which delivers health management, in-home care services, and telehealth solutions to government and corporate customers. Based in Victoria, it serves Australian residents, nonresidents, and overseas visitors.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
